These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 8293436

  • 21. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 22. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M, Iacob G, Lucan C, Lăpuşan C, Munteanu A, Sîrbu S.
    Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [Abstract] [Full Text] [Related]

  • 23. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 24. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 25. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 26. [Characteristics of the early postoperative period following kidney allotransplantation and immunosuppression using Sandimmune (cyclosporin A)].
    Belorusov OS, Iurasov SE.
    Khirurgiia (Mosk); 1991 Jul; (7):8-11. PubMed ID: 1921207
    [Abstract] [Full Text] [Related]

  • 27. [Cyclosporin A in preventive therapy after kidney transplantation: a double combination versus a triple combination. II. Adverse effects of cyclosporin A and therapeutic complications].
    Matl I, Jirka J, Kocandrle V, Petrásek R.
    Cas Lek Cesk; 1990 May 04; 129(18):554-7. PubMed ID: 2350774
    [Abstract] [Full Text] [Related]

  • 28. [Effect of immunosuppressive treatment on the crystalline lenses of patients after kidney transplantation].
    Dróbecka-Brydakowa E.
    Klin Oczna; 1991 Dec 04; 93(12):332-3. PubMed ID: 1819669
    [Abstract] [Full Text] [Related]

  • 29. Family-based program to promote medication compliance in renal transplant children.
    Fennell RS, Foulkes LM, Boggs SR.
    Transplant Proc; 1994 Feb 04; 26(1):102-3. PubMed ID: 8108894
    [No Abstract] [Full Text] [Related]

  • 30. Alternate day prednisone treatment may increase kidney transplant rejection.
    Leb DE.
    Proc Clin Dial Transplant Forum; 1979 Feb 04; 9():136-9. PubMed ID: 399501
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Lysozyme activity in undiluted and diluted blood of patients treated with cyclosporin A with prednisone or azathioprine with prednisone after kidney transplantation].
    Hrycek A, Szołtysik I, Grzeszczak W.
    Pol Arch Med Wewn; 1992 Jul 04; 88(1):11-7. PubMed ID: 1454654
    [Abstract] [Full Text] [Related]

  • 33. Protective effect of cyclosporine in human renal posttransplant cryptococcosis.
    Sampaio M, Ianhez LE, Sabbaga E.
    Transplant Proc; 1992 Dec 04; 24(6):3091. PubMed ID: 1466069
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Serum gastrin level in patients treated with cyclosporin A or azathioprine with prednisone after kidney transplantation].
    Zukowska-Szczechowska E, Grzeszczak W, Kokot F, Nieszporek T, Kuśmierski S, Kurzbauer R, Szkodny A.
    Pol Tyg Lek; 1992 Dec 04; 43(31-32):1014-6. PubMed ID: 3070501
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Metabolic differentiation of peripheral blood lymphocytes after kidney transplantation in relation to post-transplantation immuno- suppression in the light of the analysis of cellular activity of DNA transcription enzymes].
    Adamiec R, Szewczyk Z, Szopa J.
    Pol Arch Med Wewn; 1991 Oct 04; 86(4):209-19. PubMed ID: 1813875
    [Abstract] [Full Text] [Related]

  • 39. Methods for comparing cumulative hazard functions in a semi-proportional hazard model.
    Dabrowska DM, Doksum KA, Feduska NJ, Husing R, Neville P.
    Stat Med; 1992 Aug 04; 11(11):1465-76. PubMed ID: 1410960
    [Abstract] [Full Text] [Related]

  • 40. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. IV. Encorton and immuran].
    Gawlik Z, Juska D, Lewandowska T, Tyszkiewicz Z.
    Patol Pol; 1984 Aug 04; 35(1):77-90. PubMed ID: 6493824
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.